MCT System

Photothermal biomodulation.
One step beyond cells.

MCT Unit and MCT Kit: two certified medical devices that apply controlled light and temperature to the patient’s own biological material, at the point of care.

Contact usExplore the systemScientific evidence

CE Class IIa & IIb
Medical devices

ISO 13485
Quality management

Why the MCT System

What makes the MCT System different?

Autologous

Works with the patient’s own platelet-rich plasma (PRP), processed at the point of care.

Read the evidence

Controlled process

Each preset defines specific light wavelength, temperature and exposure time parameters to ensure controlled and standardized processing conditions.

Read the evidence

Photothermal biomodulation

Specific wavelengths of light combined with controlled temperature, applied inside a single-use MCT Kit.

How it works

The system

Two devices. One system.

MCT Unit applies the light and the temperature. MCT Kit holds the autologous preparation while it is conditioned.

Device 01

MCT Unit®

The MCT Unit delivers photothermal conditioning through predefined protocols combining specific light wavelengths, temperatures and exposure times.

Device 02

MCT Kit®

A patented, single-use cassette in medical-grade polymer, designed for light and thermal transmission. It holds up to 10 mL of autologous preparation.

Presets

One system, three presets.

Each preset uses predefined light wavelengths, exposure times and, where applicable, temperature settings to condition autologous PRP.

MCT Unit touchscreen showing its three presets: PRP, Cells and Exosomes

PRP

MCT Plasma

Combines red light and controlled cooling (4 °C) to prime platelets in PRP, modulating growth factor release.

Explore MCT Plasma

CELLS

MCT Cells

Combines red and near-infrared light through a predefined photobiomodulation protocol, with specific wavelengths, fluences and exposure times to ensure controlled and reproducible light exposure.

Ask our team

EXOSOMES

MCT Exosomes

Combines blue light and controlled temperature (37 °C) to stimulate the release of exosomes from the patient’s own platelets, obtaining an autologous PRP enriched with platelet-derived exosomes.

Explore MCT Exosomes

Add-on

Exo-Tech

An add-on to the MCT Exosomes protocol that combines autologous plasma gel with PRP enriched with platelet-derived exosomes, creating an injectable autologous matrix.

The technology

Photothermal biomodulation

Two physical stimuli, light and temperature, applied under controlled conditions to the patient’s own PRP inside the MCT Kit.

Increased levels of growth factors

Photothermal biomodulation primes platelets before clinical application. Studies have reported increased levels of selected growth factors following PRP conditioning, while platelet priming may also influence their release kinetics over time.

Enhanced ATP production

Light at specific wavelengths can interact with mitochondrial photoacceptors, influencing cellular energy metabolism and ATP production.

Regenerative potential across therapeutic areas

Published clinical studies have reported promising findings with photothermally conditioned PRP across different therapeutic areas, supporting its potential in regenerative medicine.

Improved platelet performance

The MCT System photothermally conditions previously prepared PRP to prime platelets. It complements the PRP preparation process through predefined light and temperature protocols.

MCT Academy

Backed by published research

Scientific publications and expert webinars on photothermal biomodulation, from bench to clinical practice.

Explore MCT AcademyAll publications
Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasma
Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasmaMCT PublicationsRegenerative Medicine

Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasma

MethodsX · 2026 — Laura Cordero, Elena Sánchez-Vizcaíno Mengual, Hernán Pinto
Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategy
Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategyMCT PublicationsRegenerative Medicine

Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategy

Regenerative Therapy · 2026 — Elena Sánchez-Vizcaíno Mengual, Laura Cordero, Hernán Pinto
Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case report
Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case reportMCT PublicationsOrthopedics

Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case report

Journal of Orthopaedic Reports · 2025 — Alberto Sánchez Herrera

Workflow

The MCT System protocol

A controlled three-step process at the point of care.

01

Obtain autologous PRP

Collect the patient’s blood and prepare PRP using the selected PRP preparation system, following the manufacturer’s instructions.

02

Load the MCT Kit®

Transfer up to 10 mL of prepared PRP into the single-use MCT Kit.

03

Run the preset on the MCT Unit®

Select the appropriate preset according to the desired biologic effect. The MCT Unit automatically applies the predefined light and temperature settings for photothermal conditioning.

Clinical areas

One system, multiple medical specialties.

PRP is used across diverse clinical applications. The MCT System introduces an innovative approach to PRP preparation through controlled photothermal conditioning, supported by scientific and clinical evidence.

Orthopedics

Osteoarthritis, tendinopathies and musculoskeletal injuries.

Clinical dermatology

Chronic and acute wounds, tissue repair, burns and post-surgical recovery.

Trichology

Androgenetic alopecia, alopecia areata and seborrheic dermatitis.

Aesthetic medicine

Skin quality improvement, scar management and pigmentation disorders.

Contact

Talk to our team

Tell us about your practice or distribution network, and our team will get back to you.